The Promise of COVID-19 Hyperimmune Immune Globulin Therapy
As of this writing, NIAID and industry collaborators are also finalizing the design of a large-scale trial to assess whether COVID-Ig can reduce the rate of hospitalization and other medical encounters in earlier-stage COVID-19 patients exhibiting mild to moderate symptoms.
Plasma Therapies: Effective COVID-19 Treatments?
Studies shed light on whether high-dose intravenous immune globulin, convalescent plasma and hyperimmune globulin will be effective therapeutic options for the novel coronavirus.
No Place Like Home: The Growing Acceptance of Subcutaneous Immune Globulin
Is SCIG well-accepted by most patients either previously treated with IVIG or just starting out on IG therapy?
Understanding Cogan’s Syndrome
This extremely rare disease affects mostly younger adults, and its cause remains a mystery.
Breakthroughs in Stem Cell Research
Optimism continues to grow about the use of stem cells in regenerative medicine highlighted by hundreds of successful clinical trials.
The Doctor Will Tweet You Now
Social media continues to shape and influence the evolving healthcare landscape.
The mHealth Revolution: An Alternative to Traditional Healthcare
With the growing number of healthcare apps, patients and providers need to be aware of their benefits, as well as their shortfalls that could affect patient care.
Exploring New Vaccine Delivery Methods
Some promising new methods for delivering vaccinations could mean a pain-free alternative, the elimination of accidental needlesticks and reduced risk of infections.
Counteracting the Anti-Vaccine Movement
Social media platforms have given the anti-vaccine faction a significant voice that has undermined advances in public health. Now, in the wake of a global pandemic, healthcare stakeholders may have an opportunity to reclaim the narrative about vaccines with facts, not fiction.
Trends in U.S. Vaccine Compliance
While vaccination rates in the U.S. are rising, they are still too low among all age groups.
